Integrated platform for cancer diagnosis utilizing liquid biopsy techniques with CRISPR/Cas9 technology. Includes complete workflow from sample collection through DNA sequencing to result analysis.
Manufactured by
Seoul, South Korea
GeneCker is a biotechnology company specializing in ultra-precision CRISPR technology and the MUTE-Seq® platform—an ultrasensitive liquid-biopsy NGS solution. From research and development to kit manufacturing, we provide an end-to-end service for advanced cancer genomics. Our flagship CRISPincette MultiCancer kit incorporates both our patented MUTE-Seq® and CRISPR Cas9 technologies to enrich variant-containing DNA fragments for accurate multi-cancer risk assessment. With operations in Korea, China, and other global markets, GeneCker delivers solutions for Multi-Cancer Early Detection (MCED) and Minimal Residual Disease (MRD) monitoring at ~20× higher analytical precision and one-tenth the per-sample cost compared to conventional UMI-based NGS.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
guangzhou biotron technolongy co.,ltd
China · 1 relevant product
Burning Rock Dx Co. Ltd.
China · 2 relevant products
NOROVA
China · 4 relevant products
HealthTec Logix
Kuwait · 2 relevant products
GENETRON HEALTH (BEIJING) CO., LTD
China · 3 relevant products
Planet Innovation Pty Ltd.
United States · 1 relevant product
Aliko Scientific SA
France · 4 relevant products
Shenzhen YHLO Biotech Co., Ltd.
China · 1 relevant product
Guangzhou Wondfo Biotech Co., Ltd.
China · 1 relevant product
Cambrian Bioworks LLC
United States · 1 relevant product
28 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →2 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 57 closest product alternatives
guangzhou biotron technolongy co.,ltd · China
Advanced liquid biopsy system for non-invasive detection and analysis of circulating tumor markers, circulating tumor cells, and cell-free DNA from blood samples.
Burning Rock Dx Co. Ltd. · China
Circulating tumor DNA detection and analysis system for cancer diagnosis and monitoring. Enables early cancer detection through blood-based liquid biopsy technology with high sensitivity and specificity.
NOROVA · China
An independently developed platform for detecting circulating tumor DNA with high sensitivity and specificity compared to traditional detection methods. This liquid biopsy approach enables non-invasive, painless diagnosis through a single blood sample for comprehensive cancer patient support.
HealthTec Logix · Kuwait
Integrated diagnostic platform combining genomic sequencing with molecular analysis for precision medicine applications. Enables personalized treatment planning and early disease detection.
GENETRON HEALTH (BEIJING) CO., LTD · China
Multi-biomarker screening solution for early-stage cancer identification. Analyzes blood samples to detect cancer-associated molecular signatures. Facilitates timely clinical intervention and improved patient outcomes.
Planet Innovation Pty Ltd. · United States
A low-cost point-of-care and at-home molecular diagnostic platform utilizing isothermal RT-LAMP and CRISPR-mediated detection without requiring sample purification steps.
Aliko Scientific SA · France
Advanced genetic testing platform for cancer diagnosis and personalized medicine applications. The system has been validated across thousands of real-world clinical scenarios for reliability and accuracy.
NOROVA · China
An independently developed liquid biopsy platform for detecting circulating tumor cells with high sensitivity and specificity. This non-invasive blood-based test provides comprehensive tumor-related information for malignant tumor diagnosis and treatment guidance.
Shenzhen YHLO Biotech Co., Ltd. · China
An integrated biochemistry testing platform for clinical laboratory diagnostics. The system encompasses multiple biochemical assays approved for clinical use in patient sample analysis.
Guangzhou Wondfo Biotech Co., Ltd. · China
Molecular diagnostics platform for nucleic acid detection and amplification-based testing. Enables identification of pathogens and genetic markers for infectious disease and other molecular-based diagnoses.
Cambrian Bioworks LLC · United States
Automated platform for molecular diagnostics of infectious pathogens. Integrates nucleic acid extraction and amplification for rapid disease identification.
Intelligenome · United States
IntelliGenome's proprietary CRISPR technology platform for decentralized diagnostics. Accurately detects pathogens and monitors treatment response across multiple applications including TB and oncology.
45 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products